DINMEK TABLET belongs to the class of ‘antiretrovirals,’ used to treat HIV infection. DINMEK TABLET helps in decreasing the chance of developing AIDS (acquired immunodeficiency syndrome). HIV (Human Immunodeficiency Virus) is a virus that attacks the immune system and destroys the white blood cells that help in fighting infection, making the individual susceptible to other infections or illnesses.

DINMEK TABLET is a combination of three medicines: Efavirenz, Lamivudine, and Tenofovir disoproxil. Efavirenz is a non-nucleoside reverse transcriptase inhibitor. Lamivudine is a nucleoside reverse transcriptase inhibitor. Tenofovir disoproxil is a nucleotide reverse transcriptase inhibitor. They work by inhibiting the reverse transcriptase enzyme, which is essential for the reproduction of the virus. 

Your doctor will decide the dosage based on your medical condition. Sometimes, DINMEK TABLET may have common side effects like nausea, headache, dizziness, depression, sleeping problems, weakness, tiredness, cough, rash, unusual dreams, concentration problems, drowsiness (sleepiness), and diarrhoea. These side effects do not require medical attention and gradually resolve over time. However, if these side effects persist for a longer time, please seek medical advice.

Let your doctor know if you are using a prescription, non-prescription drugs, and herbal products before starting DINMEK TABLET . If you are known to be allergic to DINMEK TABLET or its inactive components, please inform your doctor. Please tell your doctor if you have any heart problems, liver or kidney diseases, alcohol addiction, fits, high cholesterol levels, and weak/broken bones. If you are pregnant, please consult your doctor before taking DINMEK TABLET . Do not breastfeed while taking DINMEK TABLET . DINMEK TABLET is recommended for children who weigh at least 77 pounds (35 kg).

DINMEK TABLET is used to treat HIV infection. It consists of three medicines, namely: Efavirenz, Lamivudine, and Tenofovir disoproxil. Efavirenz belongs to the class of non-nucleoside reverse transcriptase inhibitors. Lamivudine is a nucleoside reverse transcriptase inhibitor, whereas Tenofovir disoproxil is a nucleotide reverse transcriptase inhibitor. They work by inhibiting the reverse transcriptase enzyme, which is essential for the reproduction of the virus. 

Let your doctor know if you are using a prescription, non-prescription drugs, and herbal products before starting DINMEK TABLET . Inform your doctor if you are allergic to DINMEK TABLET or its inactive components. Please inform your doctor if you have heart problems, liver (hepatitis B or C, cirrhosis) or kidney diseases, depression, pancreas (inflammation of the pancreas), alcohol addiction, fits, high cholesterol levels, and weak/broken bones (osteoporosis). You are advised to take proper precautions if you are infected with HIV infection to prevent the spread of infection to others through sexual contact or body fluids. DINMEK TABLET should be used with caution due to the increased risk of immune reconstitution syndrome, decreased bone mineral density, pancreatitis, and lactic acidosis. Pregnant women should consult their doctor before taking DINMEK TABLET . It is not recommended to breastfeed while using DINMEK TABLET since it excretes into the breast milk. DINMEK TABLET may cause dizziness/drowsiness, so do not drive or operate heavy machinery if you feel dizzy or drowsy.

Regular kidney and liver function tests, bone mineral density tests are recommended while taking DINMEK TABLET .